Trial · NCT03327571
Adverse events1,148
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,148
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Neutropenia | Blood and lymphatic system disorders | Group 1: cHL | 256 | 1,598 | |
| other | Neutropenia | Blood and lymphatic system disorders | Group 2: RRHL | 80 | 426 | |
| other | Leukopenia | Blood and lymphatic system disorders | Group 1: cHL | 68 | 1,598 | |
| other | Leukopenia | Blood and lymphatic system disorders | Group 2: RRHL | 24 | 426 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Group 1: cHL | 56 | 1,598 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Group 2: RRHL | 29 | 426 | |
| other | Anaemia | Blood and lymphatic system disorders | Group 1: cHL | 46 | 1,598 | |
| other | Anaemia | Blood and lymphatic system disorders | Group 2: RRHL | 20 | 426 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Group 1: cHL | 27 | 1,598 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Group 2: RRHL | 20 | 426 | |
| other | Bone marrow failure | Blood and lymphatic system disorders | Group 1: cHL | 22 | 1,598 | |
| other | Bone marrow failure | Blood and lymphatic system disorders | Group 2: RRHL | 12 | 426 | |
| other | Erythropenia | Blood and lymphatic system disorders | Group 1: cHL | 5 | 1,598 | |
| other | Erythropenia | Blood and lymphatic system disorders | Group 2: RRHL | 1 | 426 | |
| other | Pancytopenia | Blood and lymphatic system disorders | Group 1: cHL | 3 | 1,598 | |
| other | Pancytopenia | Blood and lymphatic system disorders | Group 2: RRHL | 1 | 426 | |
| other | Agranulocytosis | Blood and lymphatic system disorders | Group 1: cHL | 1 | 1,598 | |
| other | Agranulocytosis | Blood and lymphatic system disorders | Group 2: RRHL | 1 | 426 | |
| other | Autoimmune haemolytic anaemia | Blood and lymphatic system disorders | Group 1: cHL | 1 | 1,598 | |
| other | Autoimmune haemolytic anaemia | Blood and lymphatic system disorders | Group 2: RRHL | 1 | 426 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03327571/events